Balchem (NASDAQ:BCPC) Stock Price Expected to Rise, HC Wainwright Analyst Says

Balchem (NASDAQ:BCPC) had its price target raised by equities researchers at HC Wainwright from $185.00 to $190.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the basic materials company’s stock. HC Wainwright’s target price points to a potential upside of 8.38% from the company’s previous close.

Separately, StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a research report on Monday, October 28th.

Balchem Trading Up 1.6 %

BCPC opened at $175.31 on Monday. Balchem has a fifty-two week low of $116.84 and a fifty-two week high of $186.03. The firm has a market capitalization of $5.70 billion, a PE ratio of 47.13, a P/E/G ratio of 5.25 and a beta of 0.65. The company has a debt-to-equity ratio of 0.21, a current ratio of 2.98 and a quick ratio of 1.90. The company’s 50-day moving average is $171.75 and its 200 day moving average is $163.64.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in BCPC. BNP Paribas Financial Markets increased its stake in Balchem by 21.8% in the 1st quarter. BNP Paribas Financial Markets now owns 37,117 shares of the basic materials company’s stock valued at $5,751,000 after buying an additional 6,652 shares during the last quarter. Janus Henderson Group PLC lifted its holdings in Balchem by 21.3% during the first quarter. Janus Henderson Group PLC now owns 18,059 shares of the basic materials company’s stock worth $2,795,000 after acquiring an additional 3,176 shares during the period. Quantbot Technologies LP purchased a new position in Balchem in the first quarter worth $495,000. William Blair Investment Management LLC grew its stake in Balchem by 8.4% in the 2nd quarter. William Blair Investment Management LLC now owns 233,831 shares of the basic materials company’s stock valued at $35,998,000 after purchasing an additional 18,104 shares during the period. Finally, Oppenheimer Asset Management Inc. increased its position in shares of Balchem by 22.1% during the 2nd quarter. Oppenheimer Asset Management Inc. now owns 20,582 shares of the basic materials company’s stock valued at $3,169,000 after purchasing an additional 3,732 shares during the last quarter. 87.91% of the stock is owned by institutional investors.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.